Skip to main content
OpenTrials

Clinical trial condition

High Grade B-Cell Lymphoma

Explore clinical trials studying High Grade B-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

10 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

High Grade B-Cell Lymphoma trial results

Recruiting

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT06015880

Conditions
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +11 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
View Trial Details
Recruiting

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

NCT05890352

Conditions
Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +14 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 104 locations
View Trial Details
Recruiting

Immunotherapy in Lymphoma

NCT06796517

Conditions
Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B Cell Lymphoma Relapsed, +22 more
Locations
  • Seoul St. Mary Hospital Seoul, South Korea
  • Yeoido St. Mary Hospital Seoul, South Korea
View Trial Details
Completed

Treatment for Advanced B-Cell Lymphoma

NCT01859819

Conditions
Burkitt Lymphoma, Burkitt's Lymphoma, DNA Virus Infections, +18 more
Locations
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • New York Medical College Valhalla, New York, United States
  • Levine Children's Hospital Charlotte, North Carolina, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
View Trial Details
Completed

Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas

NCT03036904

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +10 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Weill Cornell Medicine New York, United States
  • Ohio State University Medical Center Columbus, Ohio, United States
View Trial Details

Related conditions